Walder Wyss has advised medmix in this transaction. Advestra acted as legal counsel to Credit Suisse and UBS. After its spin-off from Sulzer AG (SUN), medmix...
medmix’s CHF 315 Million Initial Public Offering on Swiss SIX Exchange
Zurich Insurance’s Establishment of Its Own Service Company
Advestra acted as legal counsel to Zurich. Zurich Insurance Company Ltd (Zurich) has established its own service company Zurich Switzerland Services Ltd. Through the service company...
Adecco Group AG’s €232.29 Million Accelerated Bookbuild Offering
Homburger advised Adecco Group. Advestra acted as legal counsel to the syndicate banks. Adecco Group AG, the world’s leading workforce solutions company, offering flexible placement, permanent placement,...
XP Inc.’s Strategic Investment in OHM Research
Advestra acted as legal counsel to XP XP Inc. (XP), a leading Brazilian investment company listed on Nasdaq, has entered into an agreement with OHM Research...
XP Investimentos’ Investment in Solaise
Veirano Advogados, Advestra, and Teixeira, Zanin Martins advised in the deal. XP Investimentos S.A. executed its investment in Solaise SA, a Swiss company owner of 99.99%...
Molecular Partners’ $63.8 Million Initial Public Offering in The US and Listing on NASDAQ Close
Homburger advised Molecular Partners AG in the transaction, while Davis Polk and Advestra advised the joint book-running managers and representatives of the underwriters. Molecular Partners AG,...
Bridgepoint’s Acquisition of A Majority Stake in Infinigate Holding AG
Renzenbrink & Partner advised the management of Infinigate Holding AG. Walder Wyss and Allen & Overy advised Bridgepoint in connection with this transaction. Milbank LLP, and...